Aspirin for primary prevention: Consider 'the risk'

Coronary Health Care

Volumn 5, Issue 1, 2001, Pages 45-50

  Ritchie, L D ^a   Lowe, G D O ^b   Loke, Y K ^c   Fletcher, K ^d   Begg, A ^e  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NHS TAYSIDE   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL ARTICLE; DIABETES MELLITUS; DIET; DOSE RESPONSE; DRUG SAFETY; DRUG USE; FAMILIAL INCIDENCE; FAMILY HISTORY; FEAR; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; LIFESTYLE; MALE; PRIMARY PREVENTION; PROPHYLAXIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; SMOKING; WEIGHT GAIN;

EID: 0034751410     PISSN: 13623265     EISSN: None     Source Type: Journal    
DOI: 10.1054/chec.2001.0113     Document Type: Article

References (36)

1. Low dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
2. Determination of who may derive most benefit from aspirin in primary prevention: Subgroup results from a randomised controlled trial
3. Statins and the prevention of coronary heart disease: Striking a balance that is desirable, affordable and achievable
4. Lipids and the primary prevention of coronary heart disease: A national clinical guideline
5. Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary risk derived from meta analysis of randomised trials
6. Joint British recommendations on prevention of coronary heart disease in clinical practice
7. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis
8. Final report on the aspirin component of the ongoing physicians' health study 1989 steering committee of the physicians' health study research group
9. An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease
10. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk 1998. The medical research council's general practice research framework
11. How soon after quitting smoking does the risk of a heart attack decline?
12. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: Principle results of British family heart study
13. Quetelet's index (W/H) as a measure of fatness
14. Comparison of methods for targeting CHD risk for primary prevention
15. Waist circumference as a measure for indicating need for weight management
16. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of major coronary event
17. Exercise in the prevention of coronary heart disease, today's best buy in public health
18. Guidelines for the management of hypertension: Report of the third working party of the British hypertension society
19. Aspirin, like all other drugs, is a poison
20. Role of the cardioprotective diet in preventing coronary heart disease
21. Moderate approach to promoting physical activity: The evidence and implications
22. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study
23. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/Tex CAPS. Air Force/Texas coronary atherosclerosis prevention study
24. Targeting subclinical atherosclerosis
25. Underreporting the use of dietary supplement sand nonprescription medications among patients undergoing a periodic health examination
26. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors
27. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
28. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. The Framingham heart study
29. Carotidartery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group
30. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?